Jeff Roncal

Jeff Roncal has extensive experience in the field of drug safety and pharmacovigilance. Jeff is currently serving as the Vice President and Head of Drug Safety & Pharmacovigilance at Editas Medicine since June 2023. Prior to their current role, they held various positions in the same domain, including Vice President at Editas Medicine, Vice President and Head of Safety and Pharmacovigilance at Jounce Therapeutics, and Head of Hematology, Global Drug Safety at Shire. Jeff also served as Product Safety Lead at AbbVie, Global Therapeutic Area Head, Product Safety & Pharmacovigilance at Astellas Pharma, and Senior Director, Clinical Safety & Pharmacovigilance at Otsuka America Pharmaceutical, Inc. Additionally, they have experience as Senior Director and Head, Clinical Safety and Pharmacovigilance at URL Pharma, Inc., Medical Director at MedImmune, Senior Director, Drug Safety and Pharmacoepidemiology at Bracco Diagnostics, and Vice President, Medical Informatics at Coding Plus.

Jeff Roncal completed their Bachelor of Science degree in Medical Technology at the University of Santo Tomas from 1979 to 1983. Jeff then went on to pursue a Doctor of Medicine at Angeles University Foundation from 1983 to 1988.